This scholarship page was last updated on 27 March 2021. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health

Tipo

Research/project funding

Posted on:

27 March 2021

Scadenza delle domande:

Expired

Reference Number

PAR-21-208

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Categories: Education, Health.

More Information

Visit Website